Gemcitabine Hydrochloride for Injection: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Gemcitabine Hydrochloride for Injection

• A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer
  NCT07544056 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
  NCT06202261 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
  NCT06821503 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
  NCT06079983 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 87 locations
• Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
  NCT06752811 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations

Common questions

How many recruiting trials involve Gemcitabine Hydrochloride for Injection?

5 recruiting trials across 9 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.